Preoperative radiotherapy 5 × 5 Gy and short versus long interval between surgery for resectable rectal cancer: 10-Year follow-up of the randomised controlled trial
•No differences in the overall 10-year survival between immediate and delayed surgery.•Downstaging after radiotherapy associated with significantly better 10-year survival.•Delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up.•Upstaging and the same stage after 5x...
Saved in:
Published in | Radiotherapy and oncology Vol. 164; pp. 268 - 274 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier B.V
01.11.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0167-8140 1879-0887 1879-0887 |
DOI | 10.1016/j.radonc.2021.10.006 |
Cover
Loading…
Abstract | •No differences in the overall 10-year survival between immediate and delayed surgery.•Downstaging after radiotherapy associated with significantly better 10-year survival.•Delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up.•Upstaging and the same stage after 5x5 Gy radiotherapy associated with similar survival.
Studies on short-course preoperative radiotherapy in combination with total mesorectal excision for rectal cancer reported improved local control without clear survival benefits. The optimal fractionation and interval between radiotherapy and surgery are still under debate. We, therefore, aimed to report 10-year results of a randomized clinical trial (RCT, NCT01444495) comparing different time intervals between irradiation and surgery for rectal cancer.
Data from the RCT conducted at a single academic centre were reviewed based on regular control visits with the median follow-up of 12 years. Patients with rectal cancer were randomly assigned to short-course preoperative radiotherapy (5 × 5 Gy) followed by surgery 7–10 days (short interval) or 4–5 weeks (long interval) after the end of irradiation. The primary endpoint was the local recurrence rate at 5 years. The secondary endpoints included overall survival, disease-free survival, systemic recurrence rate, and downstaging.
A total of 154 patients were randomly assigned to short (n = 77) or long interval (n = 77) surgery. The cumulative incidence of local recurrence at 10 years was 1.3% and 11.7% in the short and long-interval groups, respectively (p = 0.031). Accordingly, the incidence of systemic relapse was 14.3% versus 9.1% (p = 0.0319). There were no differences in the overall 10-year survival between patients subject to short and long-interval surgery (58% vs 61%, p = 0.754). However, patients with downstaging after radiotherapy had significantly better 10-year survival rates than non-responders.
Short-course preoperative radiotherapy with delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up. |
---|---|
AbstractList | •No differences in the overall 10-year survival between immediate and delayed surgery.•Downstaging after radiotherapy associated with significantly better 10-year survival.•Delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up.•Upstaging and the same stage after 5x5 Gy radiotherapy associated with similar survival.
Studies on short-course preoperative radiotherapy in combination with total mesorectal excision for rectal cancer reported improved local control without clear survival benefits. The optimal fractionation and interval between radiotherapy and surgery are still under debate. We, therefore, aimed to report 10-year results of a randomized clinical trial (RCT, NCT01444495) comparing different time intervals between irradiation and surgery for rectal cancer.
Data from the RCT conducted at a single academic centre were reviewed based on regular control visits with the median follow-up of 12 years. Patients with rectal cancer were randomly assigned to short-course preoperative radiotherapy (5 × 5 Gy) followed by surgery 7–10 days (short interval) or 4–5 weeks (long interval) after the end of irradiation. The primary endpoint was the local recurrence rate at 5 years. The secondary endpoints included overall survival, disease-free survival, systemic recurrence rate, and downstaging.
A total of 154 patients were randomly assigned to short (n = 77) or long interval (n = 77) surgery. The cumulative incidence of local recurrence at 10 years was 1.3% and 11.7% in the short and long-interval groups, respectively (p = 0.031). Accordingly, the incidence of systemic relapse was 14.3% versus 9.1% (p = 0.0319). There were no differences in the overall 10-year survival between patients subject to short and long-interval surgery (58% vs 61%, p = 0.754). However, patients with downstaging after radiotherapy had significantly better 10-year survival rates than non-responders.
Short-course preoperative radiotherapy with delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up. Studies on short-course preoperative radiotherapy in combination with total mesorectal excision for rectal cancer reported improved local control without clear survival benefits. The optimal fractionation and interval between radiotherapy and surgery are still under debate. We, therefore, aimed to report 10-year results of a randomized clinical trial (RCT, NCT01444495) comparing different time intervals between irradiation and surgery for rectal cancer. Data from the RCT conducted at a single academic centre were reviewed based on regular control visits with the median follow-up of 12 years. Patients with rectal cancer were randomly assigned to short-course preoperative radiotherapy (5 × 5 Gy) followed by surgery 7-10 days (short interval) or 4-5 weeks (long interval) after the end of irradiation. The primary endpoint was the local recurrence rate at 5 years. The secondary endpoints included overall survival, disease-free survival, systemic recurrence rate, and downstaging. A total of 154 patients were randomly assigned to short (n = 77) or long interval (n = 77) surgery. The cumulative incidence of local recurrence at 10 years was 1.3% and 11.7% in the short and long-interval groups, respectively (p = 0.031). Accordingly, the incidence of systemic relapse was 14.3% versus 9.1% (p = 0.0319). There were no differences in the overall 10-year survival between patients subject to short and long-interval surgery (58% vs 61%, p = 0.754). However, patients with downstaging after radiotherapy had significantly better 10-year survival rates than non-responders. Short-course preoperative radiotherapy with delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up. Highlights•No differences in the overall 10-year survival between immediate and delayed surgery. •Downstaging after radiotherapy associated with significantly better 10-year survival. •Delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up. •Upstaging and the same stage after 5x5 Gy radiotherapy associated with similar survival. Studies on short-course preoperative radiotherapy in combination with total mesorectal excision for rectal cancer reported improved local control without clear survival benefits. The optimal fractionation and interval between radiotherapy and surgery are still under debate. We, therefore, aimed to report 10-year results of a randomized clinical trial (RCT, NCT01444495) comparing different time intervals between irradiation and surgery for rectal cancer.BACKGROUNDStudies on short-course preoperative radiotherapy in combination with total mesorectal excision for rectal cancer reported improved local control without clear survival benefits. The optimal fractionation and interval between radiotherapy and surgery are still under debate. We, therefore, aimed to report 10-year results of a randomized clinical trial (RCT, NCT01444495) comparing different time intervals between irradiation and surgery for rectal cancer.Data from the RCT conducted at a single academic centre were reviewed based on regular control visits with the median follow-up of 12 years. Patients with rectal cancer were randomly assigned to short-course preoperative radiotherapy (5 × 5 Gy) followed by surgery 7-10 days (short interval) or 4-5 weeks (long interval) after the end of irradiation. The primary endpoint was the local recurrence rate at 5 years. The secondary endpoints included overall survival, disease-free survival, systemic recurrence rate, and downstaging.MATERIAL AND METHODSData from the RCT conducted at a single academic centre were reviewed based on regular control visits with the median follow-up of 12 years. Patients with rectal cancer were randomly assigned to short-course preoperative radiotherapy (5 × 5 Gy) followed by surgery 7-10 days (short interval) or 4-5 weeks (long interval) after the end of irradiation. The primary endpoint was the local recurrence rate at 5 years. The secondary endpoints included overall survival, disease-free survival, systemic recurrence rate, and downstaging.A total of 154 patients were randomly assigned to short (n = 77) or long interval (n = 77) surgery. The cumulative incidence of local recurrence at 10 years was 1.3% and 11.7% in the short and long-interval groups, respectively (p = 0.031). Accordingly, the incidence of systemic relapse was 14.3% versus 9.1% (p = 0.0319). There were no differences in the overall 10-year survival between patients subject to short and long-interval surgery (58% vs 61%, p = 0.754). However, patients with downstaging after radiotherapy had significantly better 10-year survival rates than non-responders.RESULTSA total of 154 patients were randomly assigned to short (n = 77) or long interval (n = 77) surgery. The cumulative incidence of local recurrence at 10 years was 1.3% and 11.7% in the short and long-interval groups, respectively (p = 0.031). Accordingly, the incidence of systemic relapse was 14.3% versus 9.1% (p = 0.0319). There were no differences in the overall 10-year survival between patients subject to short and long-interval surgery (58% vs 61%, p = 0.754). However, patients with downstaging after radiotherapy had significantly better 10-year survival rates than non-responders.Short-course preoperative radiotherapy with delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up.CONCLUSIONSShort-course preoperative radiotherapy with delayed surgery demonstrated an increased risk of local relapse over a 10-year follow-up. |
Author | Sierzega, Marek Szczepanik, Antoni Pach, Radoslaw Richter, Piotr Popiela, Tadeusz |
Author_xml | – sequence: 1 givenname: Radoslaw orcidid: 0000-0002-7218-6479 surname: Pach fullname: Pach, Radoslaw email: radoslaw.pach@uj.edu.pl – sequence: 2 givenname: Marek orcidid: 0000-0002-7008-9026 surname: Sierzega fullname: Sierzega, Marek – sequence: 3 givenname: Antoni surname: Szczepanik fullname: Szczepanik, Antoni – sequence: 4 givenname: Tadeusz surname: Popiela fullname: Popiela, Tadeusz – sequence: 5 givenname: Piotr surname: Richter fullname: Richter, Piotr |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34653526$$D View this record in MEDLINE/PubMed |
BookMark | eNqVUstuFDEQtFAQ2QT-ACEfucxiex6ejRBSFEFAigQScOBkeeyexIvXXuyZjeZLuObId4Qfo0cbOCChiFO321XVdlcfkYMQAxDylLMlZ7x5sV4mbWMwS8EEx9KSseYBWfBWrgrWtvKALBAmi5ZX7JAc5bxmjAlWykfksKyauqxFsyA_PiSIW0h6cDugqOjicIXH7UTr25uf329vMJxPVAdL81VMA91BymOmPoZL6sIAaac97WC4Bgg0j-kS0kT7mGiCDGbQnUfdOfHU6GAgnVDOii-gE6K8j9fFuKWxp9gW-wcbNy6DpSaGIeE9pkNy2j8mD3vtMzy5i8fk85vXn87eFhfvz9-dnV4Upip5U-i64j2redexxtpe4-crqFrOTQUAtRQgTdVqYLVcdcLWBnprDJO8FrwTclUek-d73W2K30bIg8L3GPBeB4hjVqJuRctZuZIIfXYHHbsNWLVNbqPTpH5PFwHVHmBSzDlB_wfCmZpNVGu1N1HNJs5VNBFpJ3_RjBvQoHki2vn7yK_2ZMAh7RwklY0DnLt1swvKRve_Asa74Iz2X2GCvI5jCmiA4ioLxdTHecnmHROctbIRFQq8_LfA_f1_AU_l6PQ |
CitedBy_id | crossref_primary_10_3389_fpubh_2022_962256 crossref_primary_10_1016_j_ctro_2023_100721 crossref_primary_10_3390_cancers15010270 crossref_primary_10_3390_cancers14225709 crossref_primary_10_1016_j_suronc_2023_101992 crossref_primary_10_1016_j_clcc_2022_06_001 crossref_primary_10_3389_fonc_2023_1119323 crossref_primary_10_1007_s00423_022_02603_8 |
Cites_doi | 10.1016/j.ctrv.2020.102104 10.1002/bjs.1800801040 10.1016/j.radonc.2019.03.016 10.1007/BF02305759 10.1002/14651858.CD002102.pub3 10.1007/978-3-319-08060-4_5 10.1002/1097-0142(20010815)92:4<896::AID-CNCR1398>3.0.CO;2-R 10.1055/s-0039-3402776 10.1007/s10147-015-0801-z 10.1002/cncr.24320 10.1016/S1470-2045(11)70097-3 10.1200/JCO.2005.08.144 10.1016/j.jamcollsurg.2013.12.046 10.1093/jicru/os32.1.Report62 10.1016/j.surg.2015.10.019 10.1097/01.sla.0000257358.56863.ce 10.1056/NEJM199704033361402 10.1016/j.clcc.2018.07.014 10.1056/NEJMoa010580 10.1007/s00423-011-0890-8 10.1097/DCR.0b013e31828aedcb 10.1016/S1470-2045(17)30086-4 10.1016/j.ejso.2018.05.025 10.1016/j.soc.2017.01.011 |
ContentType | Journal Article |
Copyright | 2021 Elsevier B.V. Elsevier B.V. Copyright © 2021 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2021 Elsevier B.V. – notice: Elsevier B.V. – notice: Copyright © 2021 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.radonc.2021.10.006 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-0887 |
EndPage | 274 |
ExternalDocumentID | 34653526 10_1016_j_radonc_2021_10_006 S0167814021087624 1_s2_0_S0167814021087624 |
Genre | Randomized Controlled Trial Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29P 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABMZM ABOCM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 E3Z EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W J5H KOM M27 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K UV1 WUQ X7M Z5R ZGI ZXP ~G- 0SF AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR NCXOZ AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c4316-a541f051bb06ddfa1404e4811c4eee572e7c48ae0579b2d5cefdcc071521b2793 |
IEDL.DBID | .~1 |
ISSN | 0167-8140 1879-0887 |
IngestDate | Fri Jul 11 16:38:32 EDT 2025 Wed Feb 19 02:27:53 EST 2025 Thu Apr 24 23:01:32 EDT 2025 Tue Jul 01 02:22:45 EDT 2025 Fri Feb 23 02:41:02 EST 2024 Tue Feb 25 20:09:58 EST 2025 Tue Aug 26 16:53:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Rectal cancer Short-course preoperative radiotherapy Interval surgery short-course preoperative radiotherapy rectal cancer interval surgery |
Language | English |
License | Copyright © 2021 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4316-a541f051bb06ddfa1404e4811c4eee572e7c48ae0579b2d5cefdcc071521b2793 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0002-7218-6479 0000-0002-7008-9026 |
OpenAccessLink | https://ruj.uj.edu.pl/xmlui/handle/item/284501 |
PMID | 34653526 |
PQID | 2582810397 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2582810397 pubmed_primary_34653526 crossref_primary_10_1016_j_radonc_2021_10_006 crossref_citationtrail_10_1016_j_radonc_2021_10_006 elsevier_sciencedirect_doi_10_1016_j_radonc_2021_10_006 elsevier_clinicalkeyesjournals_1_s2_0_S0167814021087624 elsevier_clinicalkey_doi_10_1016_j_radonc_2021_10_006 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-11-01 |
PublicationDateYYYYMMDD | 2021-11-01 |
PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Radiotherapy and oncology |
PublicationTitleAlternate | Radiother Oncol |
PublicationYear | 2021 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Watanabe, Itabashi, Shimada, Tanaka, Ito, Ajioka (b0060) 2015; 20 International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. Report 50.: ICRU; 1993. Erlandsson, Holm, Pettersson, Berglund, Cedermark, Radu (b0040) 2017; 18 Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, et al. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10: CD002102. Knol, Keller (b0005) 2020; 33 Ishiguro, Higashi, Watanabe, Sugihara (b0055) 2014; 218 Landberg T, Chavaudra J, Dobbs J, Gerard J-P, Hanks G, Horiot J-C, et al. Report 62. J Int Comm Radiat Units Measur. 1999;32. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg. 1993;80: 1333-6. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246: 693-701. Erlandsson, Lörinc, Ahlberg, Pettersson, Holm, Glimelius (b0125) 2019; 135 Wittekind, Compton, Quirke, Nagtegaal, Merkel, Hermanek (b0065) 2009; 115 Foster, Jones, Falk, Cooper, Francis (b0025) 2013; 56 Cedermark (b0120) 1996; 3 van Gijn, Marijnen, Nagtegaal, Kranenbarg, Putter, Wiggers (b0075) 2011; 12 Smith, Kachnic (b0010) 2017; 26 Ma, Gao, Song, Huang, Wang, Xu (b0015) 2018; 17 Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B, Stockholm Colorectal Cancer Study G. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92: 896-902. Bosch, Nagtegaal (b0110) 2014; 203 de Jong, ten Berge, Dwarkasing, Rijkers, van Eijck (b0130) 2016; 159 Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial. Eur J Surg. 1996;162: 397-402. Breugom, Bastiaannet, Boelens, Van Eycken, Iversen, Martling (b0020) 2018; 44 Folkesson, Birgisson, Pahlman, Cedermark, Glimelius, Gunnarsson (b0090) 2005; 23 Glynne-Jones, Hall, Nagtegaal (b0030) 2020; 90 Swedish Rectal Cancer, Cedermark, Dahlberg, Glimelius, Pahlman, Rutqvist (b0100) 1997; 336 Kapiteijn, Marijnen, Nagtegaal, Putter, Steup, Wiggers (b0080) 2001; 345 Pach, Kulig, Richter, Gach, Szura, Kowalska (b0035) 2012; 397 de Jong (10.1016/j.radonc.2021.10.006_b0130) 2016; 159 10.1016/j.radonc.2021.10.006_b0115 Ishiguro (10.1016/j.radonc.2021.10.006_b0055) 2014; 218 Kapiteijn (10.1016/j.radonc.2021.10.006_b0080) 2001; 345 Watanabe (10.1016/j.radonc.2021.10.006_b0060) 2015; 20 10.1016/j.radonc.2021.10.006_b0085 Breugom (10.1016/j.radonc.2021.10.006_b0020) 2018; 44 Pach (10.1016/j.radonc.2021.10.006_b0035) 2012; 397 Erlandsson (10.1016/j.radonc.2021.10.006_b0125) 2019; 135 10.1016/j.radonc.2021.10.006_b0045 Swedish Rectal Cancer (10.1016/j.radonc.2021.10.006_b0100) 1997; 336 10.1016/j.radonc.2021.10.006_b0105 van Gijn (10.1016/j.radonc.2021.10.006_b0075) 2011; 12 Wittekind (10.1016/j.radonc.2021.10.006_b0065) 2009; 115 Knol (10.1016/j.radonc.2021.10.006_b0005) 2020; 33 10.1016/j.radonc.2021.10.006_b0095 Folkesson (10.1016/j.radonc.2021.10.006_b0090) 2005; 23 Bosch (10.1016/j.radonc.2021.10.006_b0110) 2014; 203 Foster (10.1016/j.radonc.2021.10.006_b0025) 2013; 56 Erlandsson (10.1016/j.radonc.2021.10.006_b0040) 2017; 18 Ma (10.1016/j.radonc.2021.10.006_b0015) 2018; 17 10.1016/j.radonc.2021.10.006_b0050 Cedermark (10.1016/j.radonc.2021.10.006_b0120) 1996; 3 Glynne-Jones (10.1016/j.radonc.2021.10.006_b0030) 2020; 90 10.1016/j.radonc.2021.10.006_b0070 Smith (10.1016/j.radonc.2021.10.006_b0010) 2017; 26 |
References_xml | – volume: 17 start-page: 320 year: 2018 end-page: 330.e5 ident: b0015 article-title: Short-course radiotherapy in neoadjuvant treatment for rectal cancer: a systematic review and meta-analysis publication-title: Clin Colorectal Cancer – volume: 56 start-page: 921 year: 2013 end-page: 930 ident: b0025 article-title: Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature publication-title: Dis Colon Rectum – reference: Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br J Surg. 1993;80: 1333-6. – volume: 218 start-page: 969 year: 2014 end-page: 977.e1 ident: b0055 article-title: Japanese Society for Cancer of the C, Rectum Guideline C. Changes in colorectal cancer care in japan before and after guideline publication: a nationwide survey about D3 lymph node dissection and adjuvant chemotherapy publication-title: J Am Coll Surg – reference: International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. Report 50.: ICRU; 1993. – volume: 12 start-page: 575 year: 2011 end-page: 582 ident: b0075 article-title: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial publication-title: Lancet Oncol – volume: 26 start-page: 455 year: 2017 end-page: 466 ident: b0010 article-title: Evolving role of radiotherapy in the management of rectal carcinoma publication-title: Surg Oncol Clin N Am – volume: 18 start-page: 336 year: 2017 end-page: 346 ident: b0040 article-title: Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial publication-title: Lancet Oncol – volume: 115 start-page: 3483 year: 2009 end-page: 3488 ident: b0065 article-title: A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status publication-title: Cancer – reference: Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, et al. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10: CD002102. – volume: 135 start-page: 178 year: 2019 end-page: 186 ident: b0125 article-title: Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial publication-title: Radiother Oncol – volume: 3 start-page: 423 year: 1996 end-page: 430 ident: b0120 article-title: Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group publication-title: Ann Surg Oncol – volume: 159 start-page: 688 year: 2016 end-page: 699 ident: b0130 article-title: The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis publication-title: Surgery – volume: 397 start-page: 801 year: 2012 end-page: 807 ident: b0035 article-title: Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer–treatment results at 5-year follow-up publication-title: Langenbecks Arch Surg – reference: Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial. Eur J Surg. 1996;162: 397-402. – volume: 203 start-page: 41 year: 2014 end-page: 46 ident: b0110 article-title: What is “good quality” in rectal cancer surgery? The pathologist's perspective publication-title: Recent Results Cancer Res – reference: Martling A, Holm T, Johansson H, Rutqvist LE, Cedermark B, Stockholm Colorectal Cancer Study G. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma: long-term follow-up of a population-based study. Cancer. 2001;92: 896-902. – volume: 33 start-page: 134 year: 2020 end-page: 143 ident: b0005 article-title: Total mesorectal excision technique-past, present, and future publication-title: Clin Colon Rectal Surg – reference: Landberg T, Chavaudra J, Dobbs J, Gerard J-P, Hanks G, Horiot J-C, et al. Report 62. J Int Comm Radiat Units Measur. 1999;32. – reference: Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246: 693-701. – volume: 23 start-page: 5644 year: 2005 end-page: 5650 ident: b0090 article-title: Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate publication-title: J Clin Oncol – volume: 336 start-page: 980 year: 1997 end-page: 987 ident: b0100 article-title: Improved survival with preoperative radiotherapy in resectable rectal cancer publication-title: N Engl J Med – volume: 20 start-page: 207 year: 2015 end-page: 239 ident: b0060 article-title: Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer publication-title: Int J Clin Oncol – volume: 90 year: 2020 ident: b0030 article-title: The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 x5 Gy) in rectal cancer - are we too eager for surgery? publication-title: Cancer Treat Rev – volume: 345 start-page: 638 year: 2001 end-page: 646 ident: b0080 article-title: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer publication-title: N Engl J Med – volume: 44 start-page: 1338 year: 2018 end-page: 1343 ident: b0020 article-title: Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania publication-title: Eur J Surg Oncol – volume: 90 year: 2020 ident: 10.1016/j.radonc.2021.10.006_b0030 article-title: The optimal timing for the interval to surgery after short course preoperative radiotherapy (5 x5 Gy) in rectal cancer - are we too eager for surgery? publication-title: Cancer Treat Rev doi: 10.1016/j.ctrv.2020.102104 – ident: 10.1016/j.radonc.2021.10.006_b0115 doi: 10.1002/bjs.1800801040 – volume: 135 start-page: 178 year: 2019 ident: 10.1016/j.radonc.2021.10.006_b0125 article-title: Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial publication-title: Radiother Oncol doi: 10.1016/j.radonc.2019.03.016 – ident: 10.1016/j.radonc.2021.10.006_b0050 – volume: 3 start-page: 423 year: 1996 ident: 10.1016/j.radonc.2021.10.006_b0120 article-title: Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group publication-title: Ann Surg Oncol doi: 10.1007/BF02305759 – ident: 10.1016/j.radonc.2021.10.006_b0070 doi: 10.1002/14651858.CD002102.pub3 – volume: 203 start-page: 41 year: 2014 ident: 10.1016/j.radonc.2021.10.006_b0110 article-title: What is “good quality” in rectal cancer surgery? The pathologist's perspective publication-title: Recent Results Cancer Res doi: 10.1007/978-3-319-08060-4_5 – ident: 10.1016/j.radonc.2021.10.006_b0105 doi: 10.1002/1097-0142(20010815)92:4<896::AID-CNCR1398>3.0.CO;2-R – volume: 33 start-page: 134 year: 2020 ident: 10.1016/j.radonc.2021.10.006_b0005 article-title: Total mesorectal excision technique-past, present, and future publication-title: Clin Colon Rectal Surg doi: 10.1055/s-0039-3402776 – volume: 20 start-page: 207 year: 2015 ident: 10.1016/j.radonc.2021.10.006_b0060 article-title: Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer publication-title: Int J Clin Oncol doi: 10.1007/s10147-015-0801-z – volume: 115 start-page: 3483 year: 2009 ident: 10.1016/j.radonc.2021.10.006_b0065 article-title: A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status publication-title: Cancer doi: 10.1002/cncr.24320 – volume: 12 start-page: 575 year: 2011 ident: 10.1016/j.radonc.2021.10.006_b0075 article-title: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(11)70097-3 – volume: 23 start-page: 5644 year: 2005 ident: 10.1016/j.radonc.2021.10.006_b0090 article-title: Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate publication-title: J Clin Oncol doi: 10.1200/JCO.2005.08.144 – volume: 218 start-page: 969 year: 2014 ident: 10.1016/j.radonc.2021.10.006_b0055 article-title: Japanese Society for Cancer of the C, Rectum Guideline C. Changes in colorectal cancer care in japan before and after guideline publication: a nationwide survey about D3 lymph node dissection and adjuvant chemotherapy publication-title: J Am Coll Surg doi: 10.1016/j.jamcollsurg.2013.12.046 – ident: 10.1016/j.radonc.2021.10.006_b0045 doi: 10.1093/jicru/os32.1.Report62 – volume: 159 start-page: 688 year: 2016 ident: 10.1016/j.radonc.2021.10.006_b0130 article-title: The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis publication-title: Surgery doi: 10.1016/j.surg.2015.10.019 – ident: 10.1016/j.radonc.2021.10.006_b0085 doi: 10.1097/01.sla.0000257358.56863.ce – volume: 336 start-page: 980 year: 1997 ident: 10.1016/j.radonc.2021.10.006_b0100 article-title: Improved survival with preoperative radiotherapy in resectable rectal cancer publication-title: N Engl J Med doi: 10.1056/NEJM199704033361402 – volume: 17 start-page: 320 year: 2018 ident: 10.1016/j.radonc.2021.10.006_b0015 article-title: Short-course radiotherapy in neoadjuvant treatment for rectal cancer: a systematic review and meta-analysis publication-title: Clin Colorectal Cancer doi: 10.1016/j.clcc.2018.07.014 – volume: 345 start-page: 638 year: 2001 ident: 10.1016/j.radonc.2021.10.006_b0080 article-title: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa010580 – volume: 397 start-page: 801 year: 2012 ident: 10.1016/j.radonc.2021.10.006_b0035 article-title: Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer–treatment results at 5-year follow-up publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-011-0890-8 – volume: 56 start-page: 921 year: 2013 ident: 10.1016/j.radonc.2021.10.006_b0025 article-title: Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature publication-title: Dis Colon Rectum doi: 10.1097/DCR.0b013e31828aedcb – ident: 10.1016/j.radonc.2021.10.006_b0095 – volume: 18 start-page: 336 year: 2017 ident: 10.1016/j.radonc.2021.10.006_b0040 article-title: Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(17)30086-4 – volume: 44 start-page: 1338 year: 2018 ident: 10.1016/j.radonc.2021.10.006_b0020 article-title: Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2018.05.025 – volume: 26 start-page: 455 year: 2017 ident: 10.1016/j.radonc.2021.10.006_b0010 article-title: Evolving role of radiotherapy in the management of rectal carcinoma publication-title: Surg Oncol Clin N Am doi: 10.1016/j.soc.2017.01.011 |
SSID | ssj0002037 |
Score | 2.3530054 |
Snippet | •No differences in the overall 10-year survival between immediate and delayed surgery.•Downstaging after radiotherapy associated with significantly better... Highlights•No differences in the overall 10-year survival between immediate and delayed surgery. •Downstaging after radiotherapy associated with significantly... Studies on short-course preoperative radiotherapy in combination with total mesorectal excision for rectal cancer reported improved local control without clear... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 268 |
SubjectTerms | Dose Fractionation, Radiation Follow-Up Studies Hematology, Oncology, and Palliative Medicine Humans Interval surgery Neoadjuvant Therapy Neoplasm Recurrence, Local Neoplasm Staging Rectal cancer Rectal Neoplasms - pathology Rectal Neoplasms - radiotherapy Rectal Neoplasms - surgery Short-course preoperative radiotherapy Survival Rate |
Title | Preoperative radiotherapy 5 × 5 Gy and short versus long interval between surgery for resectable rectal cancer: 10-Year follow-up of the randomised controlled trial |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0167814021087624 https://www.clinicalkey.es/playcontent/1-s2.0-S0167814021087624 https://dx.doi.org/10.1016/j.radonc.2021.10.006 https://www.ncbi.nlm.nih.gov/pubmed/34653526 https://www.proquest.com/docview/2582810397 |
Volume | 164 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqVkJcEG-WQmUkruluvHay5VatWpZHqwqoVE6WY4_LoihZbXZV9cLf6LXH_o7yx5iJnQKCqohTNpGdyWaekb9vzNhLoyxmAWsSwGo-kXnuE5NDmqTKG4H52MsWPL63n00O5dsjdbTCxh0XhmCVMfaHmN5G63ilH99mfzad9j8SgJ76NeFHC7k09QSVMicr3_z2E-YhBqFvJvX3ptEdfa7FeM2NqytqZCjSzYDxui49XVd-tmlo9y67E-tHvh0e8R5bgeo-u7UXV8gfsIuDOdQzCP28OUqeRorVKVeX59_PLs_x8PqUm8rx5gvW3pxwGcuGl3V1zKctAhLvH-FbvAmsaY6lLSeikl0Q1YrTK8NRlkxm_opjkP2MHoOjyrI-SZYzXnuOYlF-5Wq0JHA8YuJL_NnuFPKQHe7ufBpPkrgbQ2KJLp8YJVOPLlwUg8w5b6gvD8hRmloJACoXkFs5MkDs1kI4ZcE7a7GCwQKhEBgGHrHVqq7gCeMZpKPMKAHSejlyW0VWwFbm1dDT98vA99iwU4K2sVU57ZhR6g6T9lUH1WlSHV1F1fVYcjVrFlp13DBedfrVHQ0VA6fGXHLDvPxv86CJ3t_oVDdCD_QfFvrrzN-M_B9kvugMUKPWaFHHVFAvGy1o3ZPW8_Meexws8-rfD6l5nhLZ0_-Wu85u01kgXz5jq4v5Ep5jFbYoNlo322Br2-MP7w_o-ObdZP8H-6U3fA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NbxMxELVKKkEviG_Cp5G4Lsk69m7KraooKW0iJFqpnCyvd1yCVrtRNlHVX9Jrj_0d7R_rzNobgaAq4pRoY2eSnfHMrPzeM2PvjbJYBayJALv5SKapi0wKcRQrZwTWYycb8Ph4kowO5ZcjdbTGtlsuDMEqQ-73Ob3J1uFKL9zN3mw67X0jAD3pNeFDCy1peYetkzqV6rD1rd290WSVkEXfS2eSxDdNaBl0DcxrbvKqJC1DEX_wMK-bKtRNHWhTiXYesPuhheRb_lc-ZGtQPmJ3x2GT_DG7-DqHagZe0puj5WlgWZ1ydXl-dXZ5ji-fT7kpc17_wPabEzRjWfOiKo_5tAFB4vcHBBevPXGaY3fLiatkF8S24nTXcJSlqJl_5Jhnv-OiwVFFUZ1EyxmvHEezaL_MKwwmyHmAxRf4tjks5Ak73Pl0sD2KwoEMkSXGfGSUjB2u4izrJ3nuDEnzgBzGsZUAoFIBqZVDA0RwzUSuLLjcWmxisEfIBGaCp6xTViU8ZzyBeJgYJUBaJ4f5ZpZksJk4NXD0CNN3XTZonaBtUCunQzMK3cLSfmrvOk2uo6voui6LVrNmXq3jlvGq9a9umaiYOzWWk1vmpX-bB3VIALWOdS10X_8RpL_O_C3O_8HmuzYANXqN9nVMCdWy1oK2PmlLP-2yZz4yV_9-QPp5SiQv_tvuW3ZvdDDe1_u7k72XbIM-8VzMV6yzmC_hNTZli-xNWHTXvK84mA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preoperative+radiotherapy+5%C2%A0%C3%97%C2%A05%C2%A0Gy+and+short+versus+long+interval+between+surgery+for+resectable+rectal+cancer%3A+10-Year+follow-up+of+the+randomised+controlled+trial&rft.jtitle=Radiotherapy+and+oncology&rft.au=Pach%2C+Radoslaw&rft.au=Sierzega%2C+Marek&rft.au=Szczepanik%2C+Antoni&rft.au=Popiela%2C+Tadeusz&rft.date=2021-11-01&rft.pub=Elsevier+B.V&rft.issn=0167-8140&rft.volume=164&rft.spage=268&rft.epage=274&rft_id=info:doi/10.1016%2Fj.radonc.2021.10.006&rft.externalDocID=S0167814021087624 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-8140&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-8140&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-8140&client=summon |